Donepezil effects on cholesterol and oxysterol plasma levels of Alzheimer's disease patients (2018)
- Authors:
- USP affiliated authors: FORLENZA, ORESTES VICENTE - FM ; GATTAZ, WAGNER FARID - FM
- Unidade: FM
- DOI: 10.1007/s00406-017-0838-2
- Subjects: COLESTEROL; DOENÇA DE ALZHEIMER; METABOLISMO; DEMÊNCIA
- Language: Inglês
- Imprenta:
- Publisher place: Heidelberg
- Date published: 2018
- Source:
- Título: European archives of psychiatry and clinical neuroscience
- ISSN: 0940-1334
- Volume/Número/Paginação/Ano: v. 268, n. 5, p. 501-507, 2018
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
COSTA, Alana C. et al. Donepezil effects on cholesterol and oxysterol plasma levels of Alzheimer's disease patients. European archives of psychiatry and clinical neuroscience, v. 268, n. 5, p. 501-507, 2018Tradução . . Disponível em: https://doi.org/10.1007/s00406-017-0838-2. Acesso em: 23 jan. 2026. -
APA
Costa, A. C., Joaquim, H. P. G., Nunes, V. S., Kerr, D. S., Ferreira, G. S., Forlenza, O. V., et al. (2018). Donepezil effects on cholesterol and oxysterol plasma levels of Alzheimer's disease patients. European archives of psychiatry and clinical neuroscience, 268( 5), 501-507. doi:10.1007/s00406-017-0838-2 -
NLM
Costa AC, Joaquim HPG, Nunes VS, Kerr DS, Ferreira GS, Forlenza OV, Gattaz WF, Talib LL. Donepezil effects on cholesterol and oxysterol plasma levels of Alzheimer's disease patients [Internet]. European archives of psychiatry and clinical neuroscience. 2018 ; 268( 5): 501-507.[citado 2026 jan. 23 ] Available from: https://doi.org/10.1007/s00406-017-0838-2 -
Vancouver
Costa AC, Joaquim HPG, Nunes VS, Kerr DS, Ferreira GS, Forlenza OV, Gattaz WF, Talib LL. Donepezil effects on cholesterol and oxysterol plasma levels of Alzheimer's disease patients [Internet]. European archives of psychiatry and clinical neuroscience. 2018 ; 268( 5): 501-507.[citado 2026 jan. 23 ] Available from: https://doi.org/10.1007/s00406-017-0838-2 - Increased platelet GSK3B activity in patients with mild cognitive impairment and Alzheimer's disease
- Diagnosis and biomarkers of predementia in Alzheimer’s disease
- Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study
- Inhibition of phospholipase A2 in rat brain decreases the levels of total Tau protein
- Single-nucleotide polymorphisms of GSK3B, GAB2 and SORL1 in late-onset Alzheimer's disease: interactions with the APOE genotype
- Long-term sertraline treatment increases expression and decreases phosphorylation of glycogen synthase kinase-3B in platelets of patients with late-life major depression
- Inhibition of phospolipase A2 modulates glycogen synthase activity and tau phosphorylation in primary cultures of cortical and hippocampal neurons
- Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week study
- Reduced Cerebrospinal Fluid Levels of Brain-Derived Neurotrophic Factor Is Associated With Cognitive Impairment in Late-Life Major Depression
- Increased soluble TNF receptor 2 in antidepressant-free patients with late-life depression
Informações sobre o DOI: 10.1007/s00406-017-0838-2 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
